Litcius/Paper detail

SLC4A4 is a novel driver of enzalutamide resistance in prostate cancer

Haojie Chen, Mingming Yu, Jiacheng Huang, Fuying Lan, Haihong Liao, Zihan Xu, Yongjiang Yu, Yichen Huang, Fang Chen, Yongjiang Yu, Yichen Huang, Fang Chen

2024Cancer Letters31 citationsDOI

Topics & Concepts

EnzalutamideProstate cancerMedicineOncologyCancerInternal medicineCancer researchBiologyAndrogen receptorProstate Cancer Treatment and ResearchDrug Transport and Resistance MechanismsCancer Genomics and Diagnostics
SLC4A4 is a novel driver of enzalutamide resistance in prostate cancer | Litcius